Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
11.74% 11.05% 10.51% 10.14%

+8 more TTM periods

Piotroski F-Score
8 7 8 9
ROA
5.48% 5.13% 4.77% 4.64%
ROIC
6.50% 6.59% 6.54% 6.29%
Return on Tangible Assets
20.92% 18.89% 20.49% 18.74%
Average Days of Receivables
63.72 63.24 59.14 60.06
Free Cash Flow per Share
14.33 17.00 14.59 16.68
Free Cash Flow
1,170.50 1,399.30 1,214.00 1,385.70
Other line items

Show all line items

Columns are period end dates